CRP Quantitative Testing Reagent - Vietnam Registration 230000139/PCBB-HCM
Access comprehensive regulatory information for CRP Quantitative Testing Reagent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 230000139/PCBB-HCM and manufactured by Roche Diagnostics GmbH.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Roche Diagnostics GmbH, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Technical Details
In vitro testing is used to quantify the C-reactive protein (CRP) in human serum and plasma on various systems, including the Roche/Hitachi cobas c. The CRP measurement is used to detect and assess various inflammatory disorders and related diseases, infections, and tissue damage. High-sensitivity CRP measurements can also be used to support the evaluation of the risk of coronary artery disease in the future. When used to support other diagnostic methods in the coronary artery disease syndrome, it can also be an independent prognostic indicator of recurrent events in stable coronary artery disease patients or in the coronary artery disease syndrome.
Dates and Status
Jan 18, 2023